New Pharmacologic Agents That Target Inflammation and Fibrosis in Non-Alcoholic Steatohepatitis-related Kidney Disease | Request PDF
Evangelos Akriviadis's 103 research works in Psychology and Political Science
PDF) Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
PDF) Serum Cystatin-C Is Not Superior to Serum Creatinine in Predicting Glomerular Filtration Rate in Cirrhotic Patients
PDF) Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
Evangelos Akriviadis's 103 research works in Psychology and Political Science
PDF) Assessment of Urinary Albumin/Creatinine Ratio in Non-Obese Non-Diabetic Patients with Nonalcoholic Fatty Liver Disease
PDF) Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
New Pharmacologic Agents That Target Inflammation and Fibrosis in Non-Alcoholic Steatohepatitis-related Kidney Disease | Request PDF
PDF) Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
PDF) Serum Cystatin-C Is Not Superior to Serum Creatinine in Predicting Glomerular Filtration Rate in Cirrhotic Patients
Evangelos Akriviadis's 103 research works in Psychology and Political Science
ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice | Request PDF
PDF) Assessment of Urinary Albumin/Creatinine Ratio in Non-Obese Non-Diabetic Patients with Nonalcoholic Fatty Liver Disease
PDF) Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice | Request PDF
PDF) Assessment of Urinary Albumin/Creatinine Ratio in Non-Obese Non-Diabetic Patients with Nonalcoholic Fatty Liver Disease
ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice | Request PDF
